• About
  • HS
  • ELN28
  • Team
  • Talk To Us
  • News
  • Publications

Oriented attachment of VNAR proteins, via site-selective modification, on PLGA-PEG nanoparticles enhances nanoconjugate performance

by ElasmoAdm1n | Jan 6, 2026 | Publications

João C. F. Nogueira, Michelle K. Greene, Daniel A. Richards, Alexander O. Furby, John Steven, Andrew Porter, Caroline Barelle, Christopher J. Scott and Vijay Chudasama ChemComm 2019 May. doi: 10.1039/C9CC02655J Read now…

Uveitis Therapy With Shark Variable Novel Antigen Receptor Domains Targeting Tumor Necrosis Factor Alpha or Inducible T-Cell Costimulatory Ligand

by ElasmoAdm1n | Jan 6, 2026 | Publications

Kathryn L. Pepple, Leslie Wilson, Russell N. Van Gelder, Marina Kovaleva, Obinna C. Ubah, John Steven, Caroline J. Barelle, and Andrew Porter Trans. Vis. Sci. Tech. 2019;8(5):11. doi: 10.1167/tvst.8.5.11. Read now…

In Vitro ELISA and Cell-Based Assays Confirm the Low Immunogenicity of VNAR Therapeutic Constructs in a Mouse Model of Human RA: An Encouraging Milestone to Further Clinical Drug Development

by ElasmoAdm1n | Jan 6, 2026 | Publications

Obinna C. Ubah, Andrew J. Porter, and Caroline J. Barelle Journal of Immunology Research 2020; doi: 10.1155/2020/7283239 Read now…

Isolation of highly selective IgNAR variable single-domains against a human therapeutic Fc scaffold and their application as tailor-made bioprocessing reagents

by ElasmoAdm1n | Jan 6, 2026 | Publications

Magdalena J Buschhaus, Stefan Becker, Andrew J Porter, Caroline J Barelle Protein Engineering Design and Selection 2020 doi:10.1093/protein/gzaa002   Read now…

Anti-DLL4 VNAR targeted nanoparticles for targeting of both tumour and tumour associated vasculature

by ElasmoAdm1n | Jan 6, 2026 | Publications

Leach A, Smyth P, Ferguson L, Steven J,Greene M, Branco C, McCann A, Porter A, Barelle C, Scott C Nanoscale 2020 doi:10.1039/D0NR02962A. Read now…

Non-Alcoholic Steatohepatitis (NASH) – A Review of a Crowded Clinical Landscape, Driven by a Complex Disease

by ElasmoAdm1n | Jan 6, 2026 | Publications

Fraile JM, Palliyil S, Barelle C, Porter AJ, Kovaleva M. Nanoscale Drug, Design, development and Therapy 2021; doi: 10.2147/DDDT.S315724 Read now…
« Older Entries

Recent Posts

  • Elasmogen Ltd is pleased to announce the appointment of Dr Suhail Nurbhai as Chief Medical Officer
  • Elasmogen and Intract Enter License Agreement for Soteria® and Phloral® Technologies
  • Elasmogen Researcher receives prestigious £2m fellowship to help establish him as future UK bioscience leader
  • Elasmogen announces a panel of novel, potent, anti-Covid-19 therapeutic candidates identified through collaboration with U.S. research partners
  • Elasmogen announces grants of 2 new VNAR and soloMER patent families

Recent Comments

No comments to show.
  • Follow

TALK TO US

PRIVACY POLICY

Elasmogen Ltd
Liberty Building
Foresterhill Health Campus
Foresterhill Rd
Aberdeen AB25 2ZP

Visit Us

Elasmogen Ltd

Liberty Building
Foresterhill Health Campus
Foresterhill Rd
Aberdeen AB25 2ZP

Powered by
►
Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.
None
►
Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.
None
►
Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.
None
►
Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.
None
►
Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
None
Powered by